Showing results (31-40 of 297) with videos related to
Sort By:
Pageof 30
Journal of the Neurological Sciences|May 1, 1980
Anti-ganglioside antibodies in multiple sclerosisR Arnon, E Crisp, R Kelley, et al.Journal of Immunopharmacology|January 1, 1986
Cytosine arabinoside induced changes in natural killer and antibody dependent cellular cytotoxicity functions in multiple sclerosis patientsD J Moody, J L Fahey, D Durkos-Smith, et al.Annals of Neurology|September 1, 1985
Azathioprine and steroids are not more effective in decreasing multiple sclerosis intra-blood-brain-barrier IgG synthesis than steroids aloneS M Staugaitis, P Shapshak, L W Myers, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 1, 1996
Comparative evaluations of neuroperformance and clinical outcome assessments in chronic progressive multiple sclerosis: I. Reliability, validity and sensitivity to disease progression. Multiple Sclerosis Study GroupK Syndulko, D Ke, G W Ellison, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|January 25, 2002
Factors related to agreement between self-reported and conventional Expanded Disability Status Scale (EDSS) scoresE M Cheng, R D Hays, L W Myers, et al.Annals of Neurology|March 1, 1981
Abnormal regulation of in vitro IgG production in multiple sclerosisR E Kelly, G W Ellison, L W Myers, et al.Neurology|July 1, 1988
Clinical experience with azathioprine: the prosG W Ellison, L W Myers, M R Mickey, et al.Archives of Neurology|August 1, 1987
Cyclophosphamide 'pulses' in chronic progressive multiple sclerosis. A preliminary clinical trialL W Myers, J L Fahey, D J Moody, et al.Annals of Neurology|January 1, 1994
Design strategies in multiple sclerosis clinical trials. The Cyclosporine Multiple Sclerosis Study GroupG W Ellison, L W Myers, B D Leake, et al.Bulletin of the Los Angeles Neurological Societies|April 1, 1976
Intention myoclonus in Huntington's diseaseS Novom, S Danna, M A GoldbergPageof 30